Aligos Therapeutics Inc (ALGS) Stock: Pessimism is a stepping stone to opportunity
Piper Sandler raised the price target for the Aligos Therapeutics Inc (NASDAQ:ALGS) stock from “a Neutral” to “an Overweight”. The rating was released on January 06, 2023, according to finviz. We previously noted in another research note published on January 06, 2023 by Jefferies that upgraded the stock from a Hold to a Buy with […]
Facts about Aligos Therapeutics Inc (ALGS) Stock that you might not know
Piper Sandler raised the price target for the Aligos Therapeutics Inc (NASDAQ:ALGS) stock from “a Neutral” to “an Overweight”. The rating was released on January 06, 2023, according to finviz. We previously noted in another research note published on January 06, 2023 by Jefferies that upgraded the stock from a Hold to a Buy with […]
